Surrogate alcohol: What do we know and where do we go?

被引:103
|
作者
Lachenmeier, Dirk W.
Rehm, Juergen
Gmel, Gerhard
机构
[1] Chem & Veterinarunterschungsamt, D-76187 Karlsruhe, Germany
[2] CAMH, Toronto, ON, Canada
[3] Univ Lausanne Hosp, Alcohol Treatment Ctr, Lausanne, Switzerland
[4] Swiss Inst Prevent Alcohol & Drug Problems, Lausanne, Switzerland
关键词
surrogate alcohol; moonshine; nonbeverage alcohol; illegal alcohol; homemade alcohol; methanol; lead poisoning; public health;
D O I
10.1111/j.1530-0277.2007.00474.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Consumption of surrogate alcohols (i.e., nonbeverage alcohols and illegally produced alcohols) was shown to impact on different causes of death, not only poisoning or liver disease, and appears to be a major public health problem in Russia and elsewhere. A computer-assisted literature review on chemical composition and health consequences of "surrogate alcohol" was conducted and more than 70 references were identified. A wider definition of the term "surrogate alcohol" was derived, including both nonbeverage alcohols and illegally produced alcohols that contain nonbeverage alcohols. Surrogate alcohol may contain substances that cause severe health consequences including death. Known toxic constituents include lead, which may lead to chronic toxicity, and methanol, which leads to acute poisoning. On the other hand, the role of higher alcohols (e.g., propanol, isobutanol, and isoamyl alcohol) in the etiology of surrogate-associated diseases is currently unclear. Whether other constituents of surrogates have contributed to the high all-cause mortality over and above the effect of ethanol in recent studies also remains unclear. Given the high public health importance associated with the consumption of surrogate alcohols, further knowledge on its chemical composition is required as well as research on its links to various disease endpoints should be undertaken with priority. Some interventions to reduce the harm resulting from surrogate alcohol could be undertaken already at this point. For example, the use of methanol or methanol-containing wood alcohol should be abolished in denatured alcohol. Other possible surrogates (e.g., automobile products) should be treated with bittering agents to avoid consumption.
引用
收藏
页码:1613 / 1624
页数:12
相关论文
共 50 条
  • [1] What do we know and where do we go?
    Vandiver, BJ
    COUNSELING PSYCHOLOGIST, 2002, 30 (01): : 96 - 104
  • [2] Ethical Judgments: What Do We Know, Where Do We Go?
    Peter E. Mudrack
    E. Sharon Mason
    Journal of Business Ethics, 2013, 115 : 575 - 597
  • [3] Implementing Exercise: What Do We Know? Where Do We Go?
    Painter, Patricia
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2009, 16 (06) : 536 - 544
  • [4] SUICIDE IN SCHIZOPHRENIA - WHAT DO WE KNOW - WHERE DO WE GO
    WAGMAN, AMI
    SCHIZOPHRENIA RESEARCH, 1991, 4 (03) : 378 - 379
  • [5] Ethical Judgments: What Do We Know, Where Do We Go?
    Mudrack, Peter E.
    Mason, E. Sharon
    JOURNAL OF BUSINESS ETHICS, 2013, 115 (03) : 575 - 597
  • [6] Cancer and stroke: What do we know and where do we go?
    Lun, Ronda
    Siegal, Deborah
    Ramsay, Tim
    Dowlatshahi, Dar
    THROMBOSIS RESEARCH, 2022, 219 : 133 - 140
  • [7] Cannabinoids for epilepsy: What do we know and where do we go?
    Brodie, Martin J.
    Ben-Menachem, Elinor
    EPILEPSIA, 2018, 59 (02) : 291 - 296
  • [8] BURDEN OF DISEASE CAUSED BY ALCOHOL AND ALCOHOL USE DISORDERS - WHAT DO WE KNOW AND WHERE DO WE GO?
    Rehm, J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 56A - 56A
  • [9] Alcohol Use Disorders in Primary Health Care: What Do We Know and Where Do We Go?
    Rehm, Jurgen
    Anderson, Peter
    Manthey, Jakob
    Shield, Kevin D.
    Struzzo, Pierluigi
    Wojnar, Marcin
    Gual, Antoni
    ALCOHOL AND ALCOHOLISM, 2016, 51 (04): : 422 - 427
  • [10] Round table: Ecoimmunology: what do we know, where do we go?
    Titon, S. C. M.
    Assis, V. R.
    INTEGRATIVE AND COMPARATIVE BIOLOGY, 2023, 62 : S308 - S308